Mirae Asset Sharekhan

Mirae Asset Sharekhan

OPEN DEMAT ACCOUNT

LOGIN / TRADE OPEN ACCOUNT

Follow Us :

Sharekhan

BUY NOW Buy Adline Chem Lab Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Adline Chem Lab Ltd

Tue 20/05/2025,16:0:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 14.15

Previous Close

₹ 14.41

Volume

300

Mkt Cap ( Rs. Cr)

₹8.27

High

₹ 14.15

Low

₹ 14.13

52 Week High

₹ 26.01

52 Week Low

₹ 9.40

Book Value Per Share

₹ -2.55

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Adline Chem Lab Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Adline Chem Lab Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Adline Chem Lab - Revised Outcome Of The Board Meeting

20 May 2025, 6:32PM Revised Outcome of the Board Meeting pertaining to clarification for wrong Submission of Limited Review Report instead of Audit Report for Financial R
Adline Chem Lab - Submission Of Readable Copy

13 May 2025, 6:45PM Submission of readable Copy of Audited Finacial Results along with Audit Report of the Company for the Quarter and Year Financial ended 31st March, 20
Adline Chem Lab - Financial Results For March 31, 2025

9 May 2025, 8:19PM Financial results for March 31 , 2025
Adline Chem Lab - Board Meeting Intimation for The Quarter And Financial Year Ended March 31, 2025

2 May 2025, 4:08PM Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 ,inter alia, to consider and
Adline Chem Lab - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

22 Apr 2025, 3:17PM Intimation regarding Resignation of Company Secretary & Compliance Officer pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015.
Adline Chem Lab has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

17 Apr 2025, 11:50AM As of March 2025, 29.61% is owned by Indian Promoters and 70.39% by Public. <p align=justify> Top five Promoters holding highest number of shares of A
Adline Chem Lab - Announcement under Regulation 30 (LODR)-Change in Management

12 Apr 2025, 11:15AM Appointment of Mr. Vrushank Balkrushna Patel (DIN: 05310613) as Additional Director (Non-Executive-Non-Independent) and Mr. Nilay Jitendrabhai Vaghasi
Adline Chem Lab - Board Meeting Outcome for Appointment Of Additional Directors

12 Apr 2025, 11:09AM Outcome of Board Meeting held on 12th April, 2025 for the appointment of Additional Director on the Board of Directors of the Company under Regulation
Adline Chem Lab - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations A

11 Apr 2025, 4:46PM Non-applicability of Statement of Deviation or Variation under Regulation 32 of SEBI (LODR) Regulations, 2015
Adline Chem Lab - Board Meeting Intimation for Appointment Of Additional Directors.

9 Apr 2025, 5:19PM Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/04/2025 ,inter alia, to consider and
Adline Chem Lab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

8 Apr 2025, 4:05PM Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025

Key fundamentals

Evaluate the intrinsic value of Adline Chem Lab Ltd stock

Name	March-25	March-24	March-23	March-22	March-21
Assets	-0.0017	-0.2312	-0.2343	3.9651	4.432
Liabilities	-0.0017	-0.2312	-0.2343	3.9651	4.432
Equity	5.85	5.85	5.85	5.85	5.85
Gross Profit	-0.3234	-0.1771	-0.7966	-0.2962	-0.2305
Net Profit	-0.1322	-0.1465	-4.234	0.7178	-1.2833
Cash From Operating Activities	-0.2261	-0.0196	0.0138	0.2113	-0.2941
NPM(%)	0	0	0	97.44	-20.28
Revenue	0	0	0	0.7366	6.3281
Expenses	0.3234	0.1771	0.7966	1.0328	6.5587
ROE(%)	8.87	9.84	284.26	-48.19	86.16

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2023	2024	Equity Share	6.00	5.85	5850000.00	10	5.85
2022	2023	Equity Share	6.00	5.85	5850000.00	10	5.85
2021	2022	Equity Share	6.00	5.85	5850000.00	10	5.85
2020	2021	Equity Share	6.00	5.85	5850000.00	10	5.85
2019	2020	Equity Share	6.00	5.85	5850000.00	10	5.85
2018	2019	Equity Share	6.00	5.85	5850000.00	10	5.85
2017	2018	Equity Share	6.00	5.85	5850000.00	10	5.85
2016	2017	Equity Share	6.00	5.85	5850000.00	10	5.85
2015	2016	Equity Share	6.00	5.85	5850000.00	10	5.85
2014	2015	Equity Share	6.00	5.85	5850000.00	10	5.85
2013	2014	Equity Share	6.00	5.85	5850000.00	10	5.85
2012	2013	Equity Share	6.00	5.85	5850000.00	10	5.85
2011	2012	Equity Share	6.00	5.85	5850000.00	10	5.85
2010	2011	Equity Share	6.00	5.85	5850000.00	10	5.85
2009	2010	Equity Share	6.00	5.85	5850000.00	10	5.85
2008	2009	Equity Share	6.00	5.85	5850000.00	10	5.85
2007	2008	Equity Share	6.00	5.85	5850000.00	10	5.85
2006	2007	Equity Share	6.00	5.85	5850000.00	10	5.85
2005	2006	Equity Share	6.00	5.85	5850000.00	10	5.85
2004	2005	Equity Share	6.00	5.85	5850000.00	10	5.85
1993	1996	Equity Share	6.00	5.85	5850000.00	10	5.85
1992	1993	Equity Share	6.00	5.85	5850000.00	10	5.85
1991	1992	Equity Share	6.00	0.05	50000.00	10	0.05

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Adline Chem Lab Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	810.05	-1.12	26.88	8.06	301.39	0.62
Lotus Eye Hospital and Institute Ltd	74.39	0.39	308.58	29.39	14.01	0.68
Bharat Immunological and Biologicals Corporation Ltd	25.66	-5.45	0.00	61.01	-39.50	0.00
Astec Lifesciences Ltd	698.00	-1.87	0.00	27.71	-687.11	0.00

Company Info

Karon Laboratories Ltd is an existing profit making company incorporated on 6.7.88 as a Private Ltd company. It became a public ltd company on 08.01.89. the company is engaged in formulation of pharmaceuticals. The company is promoted by Kamalesh Jagdish Laskari and his family associates. 2022 -Company name has changed to Adline Chem Lab Ltd. from Kamron Laboratories Ltd.

Karon Laboratories Ltd is an existing profit making company incorporated on 6.7.88 as a Private Ltd company. It became a public ltd company on 08.01.89. the company is engaged in formulation of pharmaceuticals. The company is promoted by Kamalesh Jagdish Laskari and his family associates. 2022 -Company name has changed to Adline Chem Lab Ltd. from Kamron Laboratories Ltd.

Read More

Parent Organisation

Adline Chem Lab Ltd.

Founded

06/07/1988

Managing Director

Mr.Pathak S B

NSE Symbol

FAQ

The current price of Adline Chem Lab Ltd is ₹ 14.13.

The 52-week high for Adline Chem Lab Ltd is

The market capitalization of Adline Chem Lab Ltd is currently ₹ 8.27. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Adline Chem Lab Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Adline Chem Lab Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Adline Chem Lab Ltd shares.

The CEO of Adline Chem Lab Ltd is Mr.Pathak S B, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT